Portfolio company
AgendX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops molecular diagnostic tests to detect pancreatic cancer for healthcare providers and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AgenDx Biosciences
This company develops a molecular diagnostics platform to provide cost-effective cancer and infectious disease testing for clinical settings and healthcare providers.
Amplified Sciences
This company develops molecular diagnostic tests and sensing platforms to help clinicians detect and monitor pancreatic cancer and other serious diseases in patients.
Amadix
This company develops blood-based liquid biopsy tests for the early detection of colorectal, lung and pancreatic cancer in patients and healthcare settings.
ORISDX
This company develops non-invasive salivary diagnostic tests for early oral cancer detection, serving dentists, oncologists and primary care providers.
Xgenera
Xgenera develops a multi-cancer early detection blood test to help clinicians and patients identify multiple cancer types at their earliest stages.
AnchorDx
This company develops non-invasive liquid biopsy tests and diagnostic tools for early cancer screening, diagnosis and recurrence monitoring for healthcare providers and patients.
Pink Dx
The company develops non-invasive molecular diagnostic tests for the early detection of gynecological cancers for women and their healthcare providers.
NX Pharmagen
This company develops molecular diagnostic tests and imaging agents for physicians and healthcare payers to improve cancer and maternal-fetal health outcomes.
